CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer

Micro-Abstract Carcinoma antigen (CA) 19-9 can be a tumor marker in addition to carcinoembryonic antigen (CEA) in the follow-up of patients with colorectal cancer. In the 7.3% of the patients who have increases of only CA 19-9, the tumor marker can be an alternative to CEA. Besides, preoperative inc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical colorectal cancer 2014-12, Vol.13 (4), p.239-244
Hauptverfasser:	Stiksma, Jolanda, Grootendorst, Diana C, van der Linden, Peter Willem G
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biomarkers, Tumor - blood CA-19-9 Antigen - blood CA19-9 Carcinoembryonic Antigen - blood CEA Colorectal Neoplasms - blood Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Female Follow-up Follow-Up Studies Gastroenterology and Hepatology Hematology, Oncology and Palliative Medicine Humans Immunoassay Liver Neoplasms - blood Liver Neoplasms - mortality Liver Neoplasms - secondary Lung Neoplasms - blood Lung Neoplasms - mortality Lung Neoplasms - secondary Lymphatic Metastasis Male Neoplasm Staging Pre-operative Prognosis Retrospective Studies Survival Rate Tumor markers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Micro-Abstract Carcinoma antigen (CA) 19-9 can be a tumor marker in addition to carcinoembryonic antigen (CEA) in the follow-up of patients with colorectal cancer. In the 7.3% of the patients who have increases of only CA 19-9, the tumor marker can be an alternative to CEA. Besides, preoperative increased levels of CA 19-9 predict a poor survival.
ISSN:	1533-0028 1938-0674
DOI:	10.1016/j.clcc.2014.09.004